chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received FLUMIST on 11/9/10. Had seizure activity 11/12 pm. Went to ER. Dxd with febrile seizure.
Patient reported fever 101.9F for atleast 24hrs after vaccination, fatigue, diarrhea, chills, and headache
I developed severe subconjuctival hemorrhage after first and second vaccine dose. Also sudden increase in my eye pressure
I started with a throat, then a cough that was just awful, I had a fever for just a day. I was out of town; I used a home COVID-19 test that came back negative. The cough persisted and was getting worse. I went to a Urgent Care, they tested me for both COVID-19 and Influenza A and B, the COVID-19 test came back positive, the influenza test came back negative. I was given a prescription for the cough, Benzonatate as well as the Paxlovid. I still have a bit of a lingering cough.
Deep, right shoulder/upper arm pain. Continued for months. Unable to have full ROM. Extreme fatigue, all day. Heart Palpitations that were maybe once a month are now several times a day.
At the time of the interview, the guardian of the minor refers that the patient is stressed by the needles and that since he was a child he has had a history of vasovagal after the administration of the vaccine, the patient appears pale and a little anxious, he refers to being dizzy. Approximately 3 min later, the patient recovers from the event and reports being well and proceeds to wait in the observation area.
Pt states after 4th Anthrax shot he started having severe flu-like symptoms, hemorrhoids, symptoms intensive, insomnia, knee joints ache and knots or lumps in the upper left arm where shots were administered. Pt states that also these symptoms continued up to or through the 5th vaccine. Pt states that after the 5th shot, the flu-like symptoms were so severe that he actually thought he had the flu. The pt states also to currently be taking medication for insomnia.
Mom presents child with 1 1/2" diameters red area with 12" dark purple core and serous drainage. Referred to private physician. Used cold on day of vaccine and in warm baths today, per mom.
Vaccine on the 14th and intermittent chest pain in the epigastric/mid sternum region without radiation started on the 15th -- no SOB, palpitations, edema or radiation of pain .  CP is at rest and with activity, feels like a spasm and lasts for couple of seconds. VS at office 11/60 and HR 68. Pt is active, wt 157, BMI 27, works out daily and eats clean. No hx of GERD or acid reflux.  EKG in office on 3/17 sinus bradycardia -- not ready by cardiologist. Troponin negative at  less than 6 on 3/17 and CRP 20 and CRP high sensitivity 24.5.  Pt sent to cardiologist whom completed other labs and EKG -- results not obtained yet but normal per pt and bradycardia. CT coronary/angiography on 3/22/22 is negative, no plaque or stenosis, calcium score is zero.  CP increased and SOB on 3/18. By 3/23 CP has decreased to very seldom and SOB has decreased.
pt recv vax & 48hr p/vax massive edema w/loss of tissue fluids, redness, swelling & fever up to 101 orally;enlarged axillary nodes, tender & palpable;swelling from shoulder to elbow;
This spontaneous report was received from a Registered Nurse referring to an approximately 27 year old female patient. The patient had no current conditions, known allergies or pertinent medical history. The patient was not taking any concomitant medications. On 09-OCT-2017, the patient was vaccinated with an expired dose of M-M-R II subcutaneously, with lot # L039613 and expiration date on 08-OCT-2017 for prophylaxis. On the same date, the patient was vaccinated with diphtheria toxoid, pertussis acellular vaccine (unspecified), tetanus toxoid. On the same date, that patient experienced pain and "it stung an burn" at the injection site while she was vaccinated with M-M-R II. It was also reported that, the patient was not immune to measles (measles antibody negative), however it was unknown if the patient received M-M-R II previously. No treatment was provided for the adverse events. At the time of the report, the outcome of measles antibody negative was unknown and the outcome of injection site pain was reported as recovered. Additionally, the reporter did not provide for causality between the adverse events and vaccination with M-M-R II. This is one of 2 reports received by the same reporter. Sender's Comments: US-009507513-1710USA014604.
Pt had severe allergic reaction to the vax (MMR, IPV, DTaP) near shock symptoms post vax. Vitals signs taken. Pt was pale and poor perfusion noted. Immediate peripheral line was started. Pt had IV saline, Benadryl, Solumedrol given, improved dramatically. Observed for 2 hours. Had stable vital signs before leaving the office.
Steady constant outbreaks, this is with vaccination, Suspected vaccination failure; Steady outbreaks, some heavier; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In JUN-2020, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Steady constant outbreaks, this is with vaccination, Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Steady outbreaks, some heavier). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 28-APR-2023 This case was reported by the patient via interactive digital media. The patient received a dose of Shingles vaccine and stated that had steady outbreaks since June 2020 and stated that some heavier than others but constant and reported that this was with vaccination. This case was considered as suspected vaccination failure as details regarding completion of vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible, as no contact details were available.
For two days after the vaccine, I had pain in my arm as I had been advised could happen. Then all was fine. One week after the vaccine, the site got a knot and turned red, feverish and itched like crazy. Whelps appeared in the redness. Whelps began to settle down after two days to a rash. It?s been 3 1/2 days since the reaction began. It is settling down, but there is still redness which is spreading down my arm. It?s slightly warm, slightly itching and a rash.
Chills; Headaches; Fever; Skin sensitivity; Nausea; Feeling unwell; This is a spontaneous report from a contactable other health professional. A 22-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, in the left arm, from 06Jan2021 08:00 at a SINGLE DOSE for COVID-19 immunization. Medical history included rubber/latex allergy. The patient was not pregnant. The patient had her 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Dec2020 in the right arm and experienced injection site soreness/pain. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. On 07Jan2021 19:00, the patient experienced chills, headaches, fever (body temperature not provided), skin sensitivity, nausea and was feeling unwell. The outcome of events was reported as recovering. No treatment was received/required due to events.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
dehydrated, unusually tired, legs hurt, extreme sore throat, nausea, eyes hurt, reduced appetite.
Came to office with a complaint of itchy rash X 1 day. Physician dx'd as "varicella".
Within 24 hours, developed headache, coryza, puffy eyes, and then itchy erythematous rash beginning at vaccine site L deltoid and spreading over 4 days to include most of L upper arm. Seen on 10/13/08.  Given a single shot of epi 0.3ml sq, and hydroxyzine 50 mg po x 1,  with resolution of headache within an hour, other symptoms gradually over next 2.5 days, no recurrance.
Patient received 1st dose of the Pfizer COVID-19 vaccine on 03/09/21 at the Health Department (SCHD). The patient came to Rx #102 to receive the 2nd dose on 03/30/21, but was inadvertently given the Moderna COVID-19 vaccine. The error was identified by the patient/family member who contacted SCHD. SCHD forwarded the information via email to Rx management on 04/20/21. The CDC was called on 04/20/21 and it was advised that the patient is considered fully vaccinated and does not need any additional doses at this time.
Vaccine induced varicella - ~20 lesions, PCR positive from 1 lesion.
Rash all over the body and swelling given epinephrine 0.18 cc and Atarax 10 mg po Q 6 hours x 3 days.
Incorrect vaccine given to patient. Patient received Pediatric Pfizer Covid vaccine. No adverse symptoms reported.
Felt stingy; Feels real cold; Arms, legs, neck, face, and body turned red; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt stingy), FEELING COLD (Feels real cold) and ERYTHEMA (Arms, legs, neck, face, and body turned red) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Skin erythema since an unknown date and Stinging since an unknown date. Concomitant products included VITAMINS NOS, MULTIVITAMIN & MINERAL, IRON FERROUS SULFATE from 15-Feb-2019 to an unknown date, FISH OIL from 01-Feb-2020 to an unknown date, NIACIN from 01-Feb-2020 to an unknown date and MONASCUS PURPUREUS (RED YEAST RICE) from 15-Feb-2020 to an unknown date for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Mar-2021, the patient experienced FEELING ABNORMAL (Felt stingy), FEELING COLD (Feels real cold) and ERYTHEMA (Arms, legs, neck, face, and body turned red). At the time of the report, FEELING ABNORMAL (Felt stingy), FEELING COLD (Feels real cold) and ERYTHEMA (Arms, legs, neck, face, and body turned red) outcome was unknown.            No treatment provided.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: ADR Form,patient demographics, medical history was updated.
After the 1st dose, I had sore arm and days later I had itchy rash around my right arm pit and my gland with swollen in the arm pit.  After 2nd vaccine, sore arm and was tired for about 48 hours.  Days later I'd noticed little itchy bumps on my left eye lid.  On the night of 4/23, now both eye lids were itchy and a bit red.  Throughout 4/24, eye lids got a little more swollen and still itchy and red, and by the evening my lips started to tinkle and a little bit swollen (it felt like I'm getting a cold sore) and I had noticed a few little bumps on the edge of my upper left side of lip (in a straight line).  Throughout 4/25 my eye lids and lip were a little more swollen and feels like I'm having cold sore/sunburn.  I
SLEEPY THAT SAME DAY, RUNNY NOSE ON DAY 2, LOSS OF SENSE OF SMELL & TASTE ON DAYS 3 & 4
Left anterior thigh with area of erythema and mild induration. No tenderness to palpation.
Covid19 breakthrough.  1st vaccine received on 03/16/2021.  93 y/o with PMHx AFIB, CHF, HTN, HLD, Hypothyroid, Urinary Retention, CKD stage 3 presents to ER via EMS with c/o worsening generalized weakness and SOB.  Pt was initially diagnosed with Covid on 02/02/2022.  Per family pt is now unable to get OOB, has decreased appetite so brought to ED for evaluation.  Afebrile, Room air sat initially normal but dropped to 83%, O2 placed on 5L NC.  CT chest suspicious for multi-focal PNA.  Pt started on IV steroids and ABX.
Infant returned to clinic on 04/20/2005 afebrile. (8 days post vaccination) with classic diffuse erythema multiforme lesions. No other known/ suspected triggers. Onset 04/17/2005
Mild headache approx 4 hours after injection.  When waking to alarm at 0600 on 25Mar21, noticed that bed was wet from sweating.  Foread was hot to the touch, ague, severe headache, light and noise sensitivity.  The room was cold, I turned up the heat in the house and put on sweatpants, socks, thermal shirt, hoodie, and beanie and could not get warm.  Began drinking water (1.5 gal by end of day at 2300).   No appetite for the entire day, nausea set on after eating a bowl of oatmeal around 1030.  Had several episodes of dry heaving, but no vomiting after eating.  Ate again at around 1900 - chicken broth and a peanut butter sandwich, nausea set on at around 1945, dry heaving, but no vomiting.  Spoke with PCM on symptoms and continued to monitor.  On 26 Mar21, cold sensation had abated, continued drinking water.  Headache, light sensitivity, nausea, and body aches for the entire day, headache has remaind constant - 6 out of 10.  Nausea at a 4.  Body Aches varied between 4-7.  Around 1100, I noticed that my neck had stiffened and it felt as if I had a tension headache.  I used a theracane, heat, and an ice pack to try and relieve the tension with no success.  I have tried relaxation techniques learned from VA to manage pain with no success.  As of 2146, stiffness is around a 6, headache is a 7, body aches 3, nausea while sitting 1, while walking 4.
A FEW MINUTES AFTER ADMIN, PATIENT STARTED FEELING BAD AND PASSED OUT  3 TIMES.  I GAVE HER WATER WHICH SEEMED TO HELP BETWEEEN EACH EPISODE.  HER EYES SEEMED TO ROLL BACK AND SHE  TWICHED  SLIGHTLY BUT CAME BACK.  HER ARM DID BLEED A LITTLE SO I CLEANED AND PLACED ANOTHER BANDAGE ON HER ARM.  PATIENT WAS FEELING BETTER AND SHE WENT HOME WITH HER SIGNIFICANT OTHER.
This spontaneous report as received from a nurse refers to a 7 months 20 days old male patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) oral, ROTATEQ lot # K016313, exp. date: 31-MAY-2016 and lot # K011663, exp. date: 20-MAY-2016 (dose and strength unspecified) oral. No concomitant medications were reported. No adverse experiences have been reported so fair. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
starting to run a fever; This is a spontaneous report from a contactable consumer (patient). A 75-years-old female patient received bnt162b2 (BNT162B2, Solution for injection, Batch/Lot Number: EN6200), dose 2 via an unspecified route of administration on 17Feb2021 as single for covid-19 immunisation (age at the vaccination 75 years old). The patient's medical history and concomitant medications were not reported. She had the second vaccine (clarified as Pfizer Covid Vaccine) yesterday. On 18Feb2021, the patient starting to run a fever. she stated that she really need to call the other number asked for help. She need to go. Reason of delay: Daily spike of incoming calls due to COVID19 vaccine. No treatment was received. Outcome of the event was not resolved.  Follow-up attempts are completed. No further information is expected.
Inflammation 4" @ site.  Physician gave 1/4 normal dose as a similar local response was noted on last shot.
1st dose 2019, 2nd not yet; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date in 2019).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose 2019, 2nd not yet). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 21-MAR-2023 The pharmacist asked if patient could receive the second dose or if the patient had to restart the vaccine series. The reporter did not had information about first dose of Shingrix (lot number, expiration date, date of administration). The reporter consented to follow up. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
Fever this morning of 103 F. Took 1,000mg of Tylenol and fever went down to 101 F. 4 hours later took another 1,000mg of tylenol and fever is currently down to 100 F. Chills Soreness at injection site Fatigue
Pt states that about 30 minutes after the shot that she took a walk during her break, which is normal, and when she got back she felt as if her blood sugar was off, she felt  very shaky. She took her B/S and it was 54. At this time the pt ate her lunch. She states she still did not feel right. She went ahead and walked again on her afternoon break, but was just feeling very tired and draggey. That evening after her supper she started chilling and her heart was racing. She did not take her temp but her b/p was 150/90 and heart rate was 90-100. She took 2 Ibuprofen and in 30 min took her b/p and heart rate again. B/P was 130/80 and Heart rate was down to 80. States she still was not feeling right. About 30 minutes after this she took her B/P again and ir was 130/72 and heart rate was down to 70. She says that she was still feeling very weak and tired. The next morning she was still feeling tired and weak and all throughout the day. but by the day after that she was feeling much better and was back to normal.
chills; fever; This is a spontaneous report from a contactable consumer (patient's wife) via the Pfizer-sponsored program. A male patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 08Feb2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 12Feb2021, the patient experienced fever and chills. The clinical outcome of fever and chills was unknown.  Information about Lot/Batch number has been requested.
rash also has blisters; This case was reported by a pharmacist via call center representative and described the occurrence of blistery rash in a 79-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 5th February 2020, the patient received the 1st dose of Shingrix .5 ml. In February 2020, 2 weeks after receiving Shingrix, the patient experienced blistery rash. On an unknown date, the outcome of the blistery rash was not recovered/not resolved.   It was unknown if the reporter considered the blistery rash to be related to Shingrix.  Additional details were reported as follows: The patient received a Shingrix and 2 weeks after her first dose presented rash on the patient's back The rash also had blisters.  The blisters resolved but presented again and were present at the time of reporting. The reporter consented to follow up. This case has been linked with case US2020152656, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020152656:same reporter
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Feb2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 44 years, in right arm for covid-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing); "sjodgrens" (unspecified if ongoing); "autoimmune neutropenia" (unspecified if ongoing); "Inflammatory arthritis" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 19Jun2022 to 24Jun2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I am a breastfeeding mother. My milk supply dropped significantly for several weeks, the visible consistency of my milk changed and my son didn?t want to drink my breast milk for a few weeks.   I also suffered from extreme dehydration post vaccination, as well as kidney pain that lasted for several weeks.
This parched feeling lasted the entire day and this morning; parched/Using the bathroom a lot from all the drinking/ thirsty; Sore Throat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 21Mar2021 (Lot number: ER8730) at the age of 57 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "High Blood Pressure" (ongoing), notes: Diagnosed about 4-5 years ago.; "Cancer" (unspecified if ongoing), notes: Had it removed 12Dec2019.; "Does not make testosterone" (ongoing); "allergy to Sulfa drugs" (unspecified if ongoing), notes: he breaks out in a little rash. Concomitant medication(s) included: EDARBI taken for hypertension, start date: 2020 (ongoing); NORVASC taken for hypertension, start date: 2020 (ongoing); TESTOSTERONE taken for hypogonadism. Vaccination history included: Flu shot (Last one about 5 years ago), administration date: 2016, reaction(s): "Sick", "Sluggish". The following information was reported: DRY MOUTH (non-serious) with onset 21Mar2021, outcome "recovering", described as "This parched feeling lasted the entire day and this morning"; THIRST (non-serious) with onset 21Mar2021, outcome "recovering", described as "parched/Using the bathroom a lot from all the drinking/ thirsty"; OROPHARYNGEAL PAIN (non-serious) with onset 21Mar2021, outcome "not recovered", described as "Sore Throat".  Additional information: The patient had no history of previous immunization with the Pfizer vaccine considered as suspect. The patient did not receive additional vaccines administered on same date of the Pfizer suspect. The patient had no prior vaccinations (within 4 weeks). The vaccine was administered between 09:00-09:15. Clinical course: The patient reported that one of the side effects he had after his vaccination was that he was parched. Started 21Mar2021, 5 minutes after getting the shot. Stated he drank three liters of water when he walked out from his vaccine, that was how thirsty he was, it drained him of anything.  Also mentions he drank 3-4 glasses of water before he went. Stated he had been using the bathroom a lot since he has been drinking a lot. Stated he also had a sore throat. This parched feeling lasted the entire day and this morning. Stated as of now it has improved. The events did not require a visit to emergency room or Physician office visit. The patient did not undergo any relevant tests.  No follow-up attempts are possible. No further information is expected.